Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan;44(1):36-50.
doi: 10.1002/cbin.11222. Epub 2019 Sep 18.

Experimental models of maternal-fetal interface and their potential use for nanotechnology applications

Affiliations
Review

Experimental models of maternal-fetal interface and their potential use for nanotechnology applications

Thádia Evelyn de Araújo et al. Cell Biol Int. 2020 Jan.

Abstract

During pregnancy, the placenta regulates the transfer of oxygen, nutrients, and residual products between the maternal and fetal bloodstreams and is a key determinant of fetal exposure to xenobiotics from the mother. To study the disposition of substances through the placenta, various experimental models are used, especially the perfused placenta, placental villi explants, and cell lineage models. In this context, nanotechnology, an area of study that is on the rise, enables the creation of particles on nanometric scales capable of releasing drugs aimed at specific tissues. An important reason for furthering the studies on transplacental transfer is to explore the potential of nanoparticles (NPs), in new delivery strategies for drugs that are specifically aimed at the mother, the placenta, or the fetus and that involve less toxicity. Due to the fact that the placental barrier is essential for the interaction between the maternal and fetal organisms as well as the possibility of NPs being used in the treatment of various pathologies, the aim of this review is to present the main experimental models used in studying the maternal-fetal interaction and the action of NPs in the placental environment.

Keywords: drug delivery systems; experimental models; maternal-fetal interaction; nanoparticles; placenta.

PubMed Disclaimer

References

REFERENCES
    1. Abdelwahed W, Degobert G, Fessi H (2006) A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization. Int J Pharm 309(1-2): 178-88. https://doi.org/10.1016/j.ijpharm.2005.10.003
    1. Abedi-Gaballu F, Dehghan G, Ghaffari M, Yekta R, Abbaspour-Ravasjani S, Baradaran B, Ezzati Nazhad Dolatabadi J, Hamblin MR (2018) PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy. Appl Materi Today 12: 177-90. https://doi.org/10.1016/j.apmt.2018.05.002
    1. Abou-Kheir W, Barrak J, Hadadeh O, Daoud G (2017) HTR-8/SVneo cell line contains a mixed population of cells. Placenta 50: 1-7. https://doi.org/10.1016/j.placenta.2016.12.007
    1. Aengenheister L, Dietrich D, Sadeghpour A, Manser P, Diener L, Wichser A, Karst U, Wick P, Buerki-Thurnherr T (2018) Gold nanoparticle distribution in advanced in vitro and ex vivo human placental barrier models. J Nanobiotechnol 16(1): 79. https://doi.org/10.1186/s12951-018-0406-6
    1. Aengenheister L, Keevend K, Muoth C, Schönenberger R, Diener L, Wick P, Buerki-Thurnherr T (2018) An advanced human in vitro co-culture model for translocation studies across the placental barrier. Sci Rep 8(5388): 5388. https://doi.org/10.1038/s41598-018-23410-6

LinkOut - more resources